Page 2 - ஆர்ல்யாஂடொ ஆரோக்கியம் அர்னால்ட் பாமர் மருத்துவமனை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Bloomberg News AP   TribLIVE s Daily and Weekly email newsletters deliver the news you want and information you need, right to your inbox. Moderna Inc. said it would expand an ongoing trial of its coronavirus vaccine in children under 12 years old to gather more safety data amid worries that messenger RNA shots may trigger rare heart side effects. “The objective is to enroll a larger safety database which increases the likelihood of detecting rarer events,” a Moderna spokeswoman said in a statement. Clinical trial timelines are regularly re-evaluated based on regulatory agency discussions and requests, she said, and Moderna expects to have data that would support authorization in late 2021 or early 2022. The Cambridge, Mass.-based company is discussing a proposal for a bigger trial with the U.S. Food and Drug Administration, she said.

New yorkUnited statesUnited kingdomWhite houseDistrict of columbiaFederico lahamAnthony fauciAbby capobiancoCenters for diseaseDrug administrationOrlando health arnold palmer hospital for childrenNew york timesPfizer incModerna incEuropean medicines agencyOrlando health arnold palmer hospital